Abstract:Cryptogenic organizing pneumonitis is a clinical and pathologic syndrome characterized by a "pneumonia-like" illness with excessive proliferation of granulation tissue within small airways and alveolar ducts associated with chronic inflammation in the surrounding alveoli. The duration of illness prior to lung biopsy is short, usually less than 2 months, and it is markedly different from that of IPF. Interestingly, unlike in IPF where the patient has difficulty remembering the exact onset of symptoms, patients with COP are frequently very specific about the timing of their disease onset. This is because the disease onset is recent and is often dramatic with the development of a severe flulike illness, ie, cough, fever, malaise, fatigue, and weight loss. Inspiratory crackles are frequently present on chest examination. Pulmonary function is usually impaired with a restrictive defect being most common. Gas exchange abnormalities are extremely common with a reduction in Dco and resting hypoxemia being almost universal findings. The roentgenographic manifestations are quite distinctive with a pattern of bilateral, diffuse but inhomogeneous, ground-glass or alveolar opacities being present in the majority of the cases. Bronchoalveolar lavage findings are nonspecific but usually reveal a lymphocytosis. The response to corticosteroid treatment is quite favorable and death from progressive disease is uncommon in COP, especially if treatment is instituted early in the course of the disease. In our experience, the cases with the worse prognosis are those associated with another disease process, in particular, connective tissue disorders like rheumatoid arthritis. In fact, these patients are prone to develop a rapidly progressive form of BOOP with a clinical course similar to the "Hamman-Rich syndrome." Recurrences are relatively frequent, consequently, withdrawal of treatment should be done with extreme caution. Corticosteroids have been the conventional initial treatment of COP, although to our knowledge, there are no controlled clinical trials to support it use. Antibiotics are not effective in treating this syndrome. Thus, based solely on our experience and that of others, we believe that high-dose corticosteroid therapy should be used to treat COP, usually initiated with 1 to 1.5 mg/kg/day (using ideal body weight) not to exceed 100 mg/day. Prednisone is given as a single oral dose in the morning. We recommended maintaining this dose for 4 to 8 weeks. If the patient's condition is stable or improved, the prednisone dosage is gradually tapered to 0.5 to 1 mg/kg/day (using ideal body weight) for the ensuing 4 to 6 weeks.(ABSTRACT TRUNCATED AT 400 WORDS)

Radiologic development of cryptogenic organizing pneumonia during follow-up:an analysis of 23 cases

A Long-Term Retrospective Study of Patients with Biopsy-Proven Cryptogenic Organizing Pneumonia

Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases

[Clinical Analysis of 25 Cases of Biopsy-Proven Cryptogenic Organizing Pneumonia].

Clinical Analysis of Pathologically Diagnosed Cryptogenic Organizing Pheumonia: A 14-Year Retrospective Analysis of 176 COP Patients.

Analysis of the Clinical Characteristics of 176 Patients with Pathologically Confirmed Cryptogenic Organizing Pneumonia

Clinicopathologic Study of Cryptogenic Organizing Pneumonia

CLINICAL ANALYSIS OF 30 CASES OF CRYPTOGENIC ORGANIZING PNEUMONIA

Clinical Analysis, Diagnosis and Treatment of 11 Cases of Cryptogenic Organizing Pneumonia

Radiographic diagnosis of cryptogenic organizing pneumonia with clinical and histological correlation

Clinical Analysis of 14 Cases of Crytogenic Organizing Penumonia

Comparative Analysis of Clinic and Pathology of Cryptogenic Organizing Pneumonia and Conventional Interstitial Pneumonia

Cryptogenic organizing pneumonitis. The North American experience

[A Report of 12 Cases of Primary Pulmonary Cryptococcosis].

Clinical and pathological features and imaging manifestations of cryptogenic organizing pneumonia

Analysis for Differences in Clinical and Radiologic Findings Between Patients with Cryptogenic Organizing Pneumonia and Connective Tissue Disorder Related Organizing Pneumonia

Clinical Analysis on 35 Cases of Pulmonary Cryptoccosis

Cryptogenic Organizing Pneumonia In Patient With Crohn'S Disease: A Case Report And Literature Review

Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides

Cryptogenic Organising Pneumonia: Clinical, Pathological, And Prognostic Analysis Of 27 Cases